Advertisement

Topics

Locus Bio Raises $19M for CRISPR-Cas3 Antimicrobial “Smart Bombs”

14:23 EST 14 Nov 2017 | Xconomy

A growing number of companies are using CRISPR technology to try and develop more precise treatments for a wide range of diseases, and Locus Biosciences is joining the mix, embracing the platform to tackle drug-resistant bacteria. Now the startup has $19 million to test its “precision antimicrobial” tech in humans. ARTIS Ventures, a San Francisco-based […]

Original Article: Locus Bio Raises $19M for CRISPR-Cas3 Antimicrobial “Smart Bombs”

NEXT ARTICLE

More From BioPortfolio on "Locus Bio Raises $19M for CRISPR-Cas3 Antimicrobial “Smart Bombs”"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...